These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 1705001

  • 1. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB, Tong WP, Chou TC.
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [Abstract] [Full Text] [Related]

  • 2. Effect of 5-azacytidine and congeners on DNA methylation and expression of deoxycytidine kinase in the human lymphoid cell lines CCRF/CEM/0 and CCRF/CEM/dCk-1.
    Antonsson BE, Avramis VI, Nyce J, Holcenberg JS.
    Cancer Res; 1987 Jul 15; 47(14):3672-8. PubMed ID: 2439195
    [Abstract] [Full Text] [Related]

  • 3. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov 15; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 4. Pharmacodynamic and DNA methylation studies of high-dose 1-beta-D-arabinofuranosyl cytosine before and after in vivo 5-azacytidine treatment in pediatric patients with refractory acute lymphocytic leukemia.
    Avramis VI, Mecum RA, Nyce J, Steele DA, Holcenberg JS.
    Cancer Chemother Pharmacol; 1989 Nov 15; 24(4):203-10. PubMed ID: 2473850
    [Abstract] [Full Text] [Related]

  • 5. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 6. A critical role for uridine nucleotides in the regulation of deoxycytidine kinase and the concentration dependence of 1-beta-D-arabinofuranosylcytosine phosphorylation in human leukemia cells.
    White JC, Capizzi RL.
    Cancer Res; 1991 May 15; 51(10):2559-65. PubMed ID: 2021937
    [Abstract] [Full Text] [Related]

  • 7. Metabolism of 1-beta-D-arabinofuranosyl-5-azacytosine and incorporation into DNA of human T-lymphoblastic cells (Molt-4).
    Townsend A, Leclerc JM, Dutschman G, Cooney D, Cheng YC.
    Cancer Res; 1985 Aug 15; 45(8):3522-8. PubMed ID: 2410096
    [Abstract] [Full Text] [Related]

  • 8. Potentiation of the activity of 1-beta-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL-60 cells: association with enhanced fragmentation of mature DNA.
    Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA.
    Cancer Res; 1992 Nov 15; 52(22):6270-8. PubMed ID: 1423273
    [Abstract] [Full Text] [Related]

  • 9. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 10. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
    Stegmann AP, Honders MW, Kester MG, Landegent JE, Willemze R.
    Leukemia; 1993 Jul 15; 7(7):1005-11. PubMed ID: 7686601
    [Abstract] [Full Text] [Related]

  • 11. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ, Colly LP, Arkesteijn GJ, Arentsen-Honders MW, Kerster MG, ter Riet PM, Willemze R.
    Cancer Res; 1990 Oct 15; 50(20):6515-9. PubMed ID: 2208110
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S, Turner A, Nelms P, Yanovich S.
    Leukemia; 1995 May 15; 9(5):808-14. PubMed ID: 7769843
    [Abstract] [Full Text] [Related]

  • 13. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
    Lee T, Karon M, Monparler RL.
    Cancer Res; 1975 Sep 15; 35(9):2506-10. PubMed ID: 50132
    [Abstract] [Full Text] [Related]

  • 14. De novo induced mutations in the deoxycytidine kinase (dck) gene in rat leukemic clonal cell lines confer resistance to cytarabine (AraC) and 5-aza-2'-deoxycytidine (DAC).
    Stegmann AP, Honders MW, Willemze R, Landegent JE.
    Leukemia; 1995 Jun 15; 9(6):1032-8. PubMed ID: 7541096
    [Abstract] [Full Text] [Related]

  • 15. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 16. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO, Mitchell BS, Ayres M, Eriksson S, Gandhi V.
    Cancer Res; 2002 Jun 01; 62(11):3100-5. PubMed ID: 12036920
    [Abstract] [Full Text] [Related]

  • 17. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM, Kuiper CM, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Peters GJ.
    Biochem Pharmacol; 2004 Feb 01; 67(3):503-11. PubMed ID: 15037202
    [Abstract] [Full Text] [Related]

  • 18. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
    Kharbanda S, Emoto Y, Kisaki H, Saleem A, Kufe D.
    Mol Pharmacol; 1994 Jul 01; 46(1):67-72. PubMed ID: 8058058
    [Abstract] [Full Text] [Related]

  • 19. In vitro biochemical and cytotoxicity studies with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine in combination.
    Momparler RL, Goodman J, Karon M.
    Cancer Res; 1975 Oct 01; 35(10):2853-7. PubMed ID: 50882
    [Abstract] [Full Text] [Related]

  • 20. Sequence-specific effects of ara-5-aza-CTP and ara-CTP on DNA synthesis by purified human DNA polymerases in vitro: visualization of chain elongation on a defined template.
    Townsend AJ, Cheng YC.
    Mol Pharmacol; 1987 Sep 01; 32(3):330-9. PubMed ID: 2444869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.